237 related articles for article (PubMed ID: 32770775)
1. Kawasaki syndrome: role of superantigens revisited.
Leung DYM; Schlievert PM
FEBS J; 2021 Mar; 288(6):1771-1777. PubMed ID: 32770775
[TBL] [Abstract][Full Text] [Related]
2. Superantigens in Kawasaki syndrome.
Leung DY; Meissner HC; Fulton DR; Quimby F; Schlievert PM
Clin Immunol Immunopathol; 1995 Nov; 77(2):119-26. PubMed ID: 7586718
[TBL] [Abstract][Full Text] [Related]
3. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome.
Leung DY; Meissner C; Fulton D; Schlievert PM
J Clin Immunol; 1995 Nov; 15(6 Suppl):11S-17S. PubMed ID: 8613483
[TBL] [Abstract][Full Text] [Related]
4. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
[TBL] [Abstract][Full Text] [Related]
5. [Immunoregulatory mechanisms of action of intravenous gammaglobulin in Kawasaki syndrome].
Marcinkiewicz J; Szymanowska Z; Mazurek A
Przegl Lek; 1998; 55(11):611-3. PubMed ID: 10216377
[TBL] [Abstract][Full Text] [Related]
6. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease.
Leung DY; Sullivan KE; Brown-Whitehorn TF; Fehringer AP; Allen S; Finkel TH; Washington RL; Makida R; Schlievert PM
Pediatr Res; 1997 Sep; 42(3):268-72. PubMed ID: 9284264
[TBL] [Abstract][Full Text] [Related]
7. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome.
Leung DY; Giorno RC; Kazemi LV; Flynn PA; Busse JB
J Immunol; 1995 Nov; 155(10):5018-21. PubMed ID: 7594509
[TBL] [Abstract][Full Text] [Related]
8. Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin.
Leung DY
Clin Exp Immunol; 1996 May; 104 Suppl 1():49-54. PubMed ID: 8625544
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
[TBL] [Abstract][Full Text] [Related]
10. Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome.
Nomura Y; Yoshinaga M; Masuda K; Takei S; Miyata K
J Infect Dis; 2002 Jun; 185(11):1677-80. PubMed ID: 12023778
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of Kawasaki disease and superantigens.
Uchiyama T; Kato H
Jpn J Infect Dis; 1999 Aug; 52(4):141-5. PubMed ID: 10592892
[TBL] [Abstract][Full Text] [Related]
12. Twenty-five types of T-cell receptor Vbeta family repertoire in patients with Kawasaki syndrome.
Nomura Y; Masuda K; Shinkoda Y; Sameshima K; Oku S; Yoshinaga M; Miyata K
Eur J Pediatr; 1998 Dec; 157(12):981-6. PubMed ID: 9877036
[TBL] [Abstract][Full Text] [Related]
13. [Kawasaki disease: an infectious disease?].
Cimaz R
Rev Med Interne; 2005 Oct; 26 Spec No 1():15-8. PubMed ID: 16475258
[No Abstract] [Full Text] [Related]
14. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China.
Ruan Y; Ye B; Zhao X
Pediatr Infect Dis J; 2013 Oct; 32(10):e397-402. PubMed ID: 23722531
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a superantigen mediated process in Kawasaki disease.
Curtis N; Zheng R; Lamb JR; Levin M
Arch Dis Child; 1995 Apr; 72(4):308-11. PubMed ID: 7763061
[TBL] [Abstract][Full Text] [Related]
16. Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome.
Saulsbury FT
Clin Pediatr (Phila); 2002 Oct; 41(8):597-601. PubMed ID: 12403377
[TBL] [Abstract][Full Text] [Related]
17. [Superantigens and toxic shock syndrome. A report of three cases treated with intravenous gammaglobulin].
Vázquez García RE; Hernández Bautista V; Espinosa Padilla S
Rev Alerg Mex; 2006; 53(5):183-8. PubMed ID: 17357565
[TBL] [Abstract][Full Text] [Related]
18. Superantigens in dermatology.
Macias ES; Pereira FA; Rietkerk W; Safai B
J Am Acad Dermatol; 2011 Mar; 64(3):455-72; quiz 473-4. PubMed ID: 21315950
[TBL] [Abstract][Full Text] [Related]
19. Kawasaki syndrome and factors associated with coronary artery abnormalities in California.
Callinan LS; Tabnak F; Holman RC; Maddox RA; Kim JJ; Schonberger LB; Vugia DJ; Belay ED
Pediatr Infect Dis J; 2012 Sep; 31(9):894-8. PubMed ID: 22565293
[TBL] [Abstract][Full Text] [Related]
20. Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease.
Burns JC; Touma R; Song Y; Padilla RL; Tremoulet AH; Sidney J; Sette A; Franco A
Autoimmunity; 2015 May; 48(3):181-8. PubMed ID: 25822882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
